vs

Side-by-side financial comparison of FRANKLIN FINANCIAL SERVICES CORP (FRAF) and NEKTAR THERAPEUTICS (NKTR). Click either name above to swap in a different company.

FRANKLIN FINANCIAL SERVICES CORP is the larger business by last-quarter revenue ($23.3M vs $21.8M, roughly 1.1× NEKTAR THERAPEUTICS). FRANKLIN FINANCIAL SERVICES CORP runs the higher net margin — 25.9% vs -165.4%, a 191.4% gap on every dollar of revenue. On growth, FRANKLIN FINANCIAL SERVICES CORP posted the faster year-over-year revenue change (51.5% vs -25.3%). Over the past eight quarters, FRANKLIN FINANCIAL SERVICES CORP's revenue compounded faster (14.6% CAGR vs 0.4%).

Franklin Financial Services Corp (Pennsylvania) is a U.S. regional bank holding company primarily operating across Pennsylvania. It provides comprehensive retail and commercial banking services, including deposit products, personal and business loans, mortgage financing, and wealth management solutions for individual consumers, small local businesses and regional institutional clients.

Nektar Therapeutics is an American biopharmaceutical company. The company was founded in 1990 and is based in San Francisco, California. The company develops new drug candidates by applying its proprietary PEGylation and advanced polymer conjugate technologies to modify chemical structure of substances, which improves drug characteristics like retention and solubility. It is a technology supplier to a number of pharmaceutical companies including Affymax, Amgen, Merck, Pfizer and UCB Pharma, e...

FRAF vs NKTR — Head-to-Head

Bigger by revenue
FRAF
FRAF
1.1× larger
FRAF
$23.3M
$21.8M
NKTR
Growing faster (revenue YoY)
FRAF
FRAF
+76.7% gap
FRAF
51.5%
-25.3%
NKTR
Higher net margin
FRAF
FRAF
191.4% more per $
FRAF
25.9%
-165.4%
NKTR
Faster 2-yr revenue CAGR
FRAF
FRAF
Annualised
FRAF
14.6%
0.4%
NKTR

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
FRAF
FRAF
NKTR
NKTR
Revenue
$23.3M
$21.8M
Net Profit
$6.0M
$-36.1M
Gross Margin
Operating Margin
32.1%
-126.9%
Net Margin
25.9%
-165.4%
Revenue YoY
51.5%
-25.3%
Net Profit YoY
1140.7%
-596.9%
EPS (diluted)
$1.35
$-4.67

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
FRAF
FRAF
NKTR
NKTR
Q4 25
$23.3M
$21.8M
Q3 25
$23.0M
$11.8M
Q2 25
$22.3M
$11.2M
Q1 25
$20.2M
$10.5M
Q4 24
$15.4M
$29.2M
Q3 24
$19.5M
$24.1M
Q2 24
$18.6M
$23.5M
Q1 24
$17.7M
$21.6M
Net Profit
FRAF
FRAF
NKTR
NKTR
Q4 25
$6.0M
$-36.1M
Q3 25
$5.4M
$-35.5M
Q2 25
$5.9M
$-41.6M
Q1 25
$3.9M
$-50.9M
Q4 24
$487.0K
$7.3M
Q3 24
$4.2M
$-37.1M
Q2 24
$3.0M
$-52.4M
Q1 24
$3.4M
$-36.8M
Gross Margin
FRAF
FRAF
NKTR
NKTR
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
72.7%
Q3 24
81.6%
Q2 24
58.5%
Q1 24
60.6%
Operating Margin
FRAF
FRAF
NKTR
NKTR
Q4 25
32.1%
-126.9%
Q3 25
28.9%
-268.6%
Q2 25
32.8%
-324.2%
Q1 25
23.9%
-425.8%
Q4 24
3.4%
49.2%
Q3 24
26.2%
-142.4%
Q2 24
19.8%
-211.9%
Q1 24
22.6%
-163.7%
Net Margin
FRAF
FRAF
NKTR
NKTR
Q4 25
25.9%
-165.4%
Q3 25
23.3%
-301.3%
Q2 25
26.4%
-372.2%
Q1 25
19.4%
-486.4%
Q4 24
3.2%
24.9%
Q3 24
21.6%
-153.6%
Q2 24
16.3%
-222.9%
Q1 24
18.9%
-170.1%
EPS (diluted)
FRAF
FRAF
NKTR
NKTR
Q4 25
$1.35
$-4.67
Q3 25
$1.19
$-1.87
Q2 25
$1.32
$-2.95
Q1 25
$0.88
$-0.24
Q4 24
$0.13
$-2.07
Q3 24
$0.95
$-2.66
Q2 24
$0.66
$-3.76
Q1 24
$0.77
$-0.19

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
FRAF
FRAF
NKTR
NKTR
Cash + ST InvestmentsLiquidity on hand
$127.7M
$15.1M
Total DebtLower is stronger
Stockholders' EquityBook value
$175.2M
$89.8M
Total Assets
$2.2B
$280.4M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
FRAF
FRAF
NKTR
NKTR
Q4 25
$127.7M
$15.1M
Q3 25
$188.1M
$41.0M
Q2 25
$207.8M
$43.0M
Q1 25
$225.0M
$38.9M
Q4 24
$203.6M
$44.3M
Q3 24
$236.3M
$30.1M
Q2 24
$179.7M
$27.9M
Q1 24
$182.6M
$48.6M
Stockholders' Equity
FRAF
FRAF
NKTR
NKTR
Q4 25
$175.2M
$89.8M
Q3 25
$166.3M
$85.1M
Q2 25
$157.4M
$-24.2M
Q1 25
$151.4M
$13.7M
Q4 24
$144.7M
$60.7M
Q3 24
$149.9M
$48.9M
Q2 24
$136.8M
$79.7M
Q1 24
$134.2M
$126.7M
Total Assets
FRAF
FRAF
NKTR
NKTR
Q4 25
$2.2B
$280.4M
Q3 25
$2.3B
$301.3M
Q2 25
$2.3B
$207.5M
Q1 25
$2.3B
$256.2M
Q4 24
$2.2B
$303.9M
Q3 24
$2.2B
$308.0M
Q2 24
$2.0B
$343.3M
Q1 24
$2.0B
$396.0M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
FRAF
FRAF
NKTR
NKTR
Operating Cash FlowLast quarter
$25.4M
$-65.0M
Free Cash FlowOCF − Capex
$-65.0M
FCF MarginFCF / Revenue
-298.0%
Capex IntensityCapex / Revenue
0.1%
Cash ConversionOCF / Net Profit
4.21×
TTM Free Cash FlowTrailing 4 quarters
$-208.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
FRAF
FRAF
NKTR
NKTR
Q4 25
$25.4M
$-65.0M
Q3 25
$8.3M
$-48.8M
Q2 25
$5.1M
$-45.7M
Q1 25
$8.8M
$-49.1M
Q4 24
$21.8M
$-46.2M
Q3 24
$7.8M
$-43.9M
Q2 24
$2.4M
$-37.7M
Q1 24
$7.3M
$-47.9M
Free Cash Flow
FRAF
FRAF
NKTR
NKTR
Q4 25
$-65.0M
Q3 25
$-48.9M
Q2 25
$-45.8M
Q1 25
$-49.1M
Q4 24
$-46.6M
Q3 24
$-44.6M
Q2 24
$-37.9M
Q1 24
$-48.0M
FCF Margin
FRAF
FRAF
NKTR
NKTR
Q4 25
-298.0%
Q3 25
-414.5%
Q2 25
-409.6%
Q1 25
-469.0%
Q4 24
-159.9%
Q3 24
-184.9%
Q2 24
-161.3%
Q1 24
-222.0%
Capex Intensity
FRAF
FRAF
NKTR
NKTR
Q4 25
0.1%
Q3 25
1.0%
Q2 25
0.3%
Q1 25
0.0%
Q4 24
1.6%
Q3 24
2.8%
Q2 24
0.8%
Q1 24
0.7%
Cash Conversion
FRAF
FRAF
NKTR
NKTR
Q4 25
4.21×
Q3 25
1.55×
Q2 25
0.87×
Q1 25
2.25×
Q4 24
44.67×
-6.36×
Q3 24
1.85×
Q2 24
0.80×
Q1 24
2.17×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons